DOC Updates

In this first episode of a three-part series on SGLT-2 inhibitors Drs. John Russell and Neil Skolnik discuss the Cardiovascular Outcome Trials (CVOTs) of the SGLT-2 inhibitors, as well as the place of the SGLT-2is in the American Diabetes Association Guidelines and answer some common practical questions about SGLT-2 inhibitor use.  In episodes 2 and 3 of this series, Drs. Russell and Skolnik we will discuss the evidence about the effects of the SGLT-2 inhibitors on renal and heart failure outcomes.     

This special episode of the Diabetes Core Update was supported by an unrestricted educational grant from the Division of Cardiovascular & Metabolic Diseases of U.S. Medical at AstraZeneca Pharmaceuticals, LP. All material is intended for medical education purposes only and contains no promotional information.

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Body Weight Variability and the Risk of Cardiovascular Outcomes and Mortality in Patients With Type 2 Diabetes
2. Health Care Utilization of Homeless Minors With Diabetes in New York State
3. The Affordable Care Act: Effects of Insurance on Diabetes Biomarkers
4. Decreased Antihyperglycemic Drug Use Driven by High Out-of- Pocket Costs Despite Medicare Coverage Gap Closure Neil
5. Effect of Flash Glucose Monitoring on glycaemic control
6. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Influence of Baseline Diastolic Blood Pressure on the Outcomes of Intensive Blood Pressure Lowering
2. Effects of an Electronic Software “Prompt” on Cardiovascular and Renal Complications in a Population With Type 2 Diabetes and Microalbuminuria
3. Randomized Trial Evaluating the Efficacy and Safety of Fast- Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec
4. Obstructive Sleep Apnea, a Risk Factor for Cardiovascular and Microvascular Disease in Patients With Type 2 Diabetes
5. Social Support, Social Network Size, Social Strain, Stressful Life Events, and Coronary Heart Disease in Women With Type 2 Diabetes
6. Whole-Grain Processing and Glycemic Control in Type 2 Diabetes: A Randomized Crossover Trial

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this second episode of a three-part series on “Disrupting Therapeutic Inertia in Diabetes Management,” Drs. John Russell, Neil Skolnik, and Stewart Harris examine discuss the consequences and causes of therapeutic inertia.  Episode three of this series, will explore  solutions for overcoming therapeutic inertia. This special three-part series on therapeutic inertia is supported by independent educational grant from Sanofi (https://www.sanofi.com).

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Stewart Harris CM MD MPH FCFP FACPM, Professor, Diabetes Canada Chair in Diabetes Management, Ian McWhinney Chair of Family Medicine Studies,  Schulich School of Medicine and Dentistry,  Western University

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Adolescent Obesity and Early-Onset Type 2 Diabetes
2. Liraglutide as add-on to sodium-glucose co-transporter-2 inhibitors in patients with inadequately controlled type 2 diabetes
3. Initial Clinical and Public Health Implications of 2019 Endocrine Society Guidelines for Diagnosis of Diabetes in Older Adults
4. Effectiveness of herbal medicines for weight loss: A systematic review and meta-analysis
5. The Association of Energy an Macronutrient Intake at Dinner Versus Breakfast With Disease-Specific and All-Cause Mortality Among People With Diabetes
6. Diabetes Self-management Education and Support in Adults with Type 2 Diabetes: A Consensus Report

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

In this first episode of the three-part series “Influenza and Diabetes,” Drs. John Russell and Neil Skolnik discuss the epidemiology of influenza, the consequences of influenza for persons with diabetes, and current recommendations for vaccination.  In addition, they discuss issues to think about when organizing our approach to influenza vaccination for this upcoming influenza season.  In episode 2 of this series, Drs. Russell and Skolnik we will look in greater depth at additional consequences of influenza in persons with diabetes. Episode 3 will discuss the different influenza vaccines in detail.   This special three-part series on therapeutic inertia is supported by independent educational grant from Sanofi Pasteur.

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

Diabetes Core Update is a monthly podcast that presents and discusses the latest clinically relevant articles from the American Diabetes Association’s four science and medical journals – Diabetes, Diabetes Care, Clinical Diabetes, and Diabetes Spectrum. Each episode is approximately 20 minutes long and presents 5-6 recently published articles from ADA journals.

Intended for practicing physicians and health care professionals, Diabetes Core Update discusses how the latest research and information published in journals of the American Diabetes Association are relevant to clinical practice and can be applied in a treatment setting.

This issue will review:

1. Combination Therapy With Canagliflozin Plus Liraglutide Exerts Additive Effect on Weight Loss, but Not on HbA1c
2. Novel Dual GIP and GLP-1 Receptor Agonist, Tirzepatide, on Biomarkers of Non-Alcoholic Steatohepatitis
3. Use of Antihyperglycemic Medications in U.S. Adults: An Analysis of the National Health and Nutrition Examination Survey
4. A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
5. Renal and Cardiovascular Outcomes After Weight Loss From Gastric Bypass Surgery in Type 2 Diabetes: Cardiorenal Risk Reductions Exceed Atherosclerotic Benefits
6. Insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks: DUAL VIII

For more information about each of ADA’s science and medical journals, please visit www.diabetesjournals.org.

Presented by:

Neil Skolnik, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health

John J. Russell, M.D., Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Director, Family Medicine Residency Program, Chair-Department of Family Medicine, Abington Jefferson Health

This special issue focuses on Inpatient care for People with Diabetes and COVID-19 answering questions from a large online audience as a launching point for discussion.  

Recorded May 14, 2020

This is a part of the American Diabetes Associations ongoing project providing resources for practicing clinicians on the care of Diabetes during the Covid-19 pandemic.  Today’s discussion is an audio version of a webinar recorded on May 14, 2020.

Presented by:

Boris Draznin, MD, PhD University of Colorado, Denver

Carol Levy, MD, CDE Icahn School of Medicine at Mount Sinai

Jing Chao, MD University of Washington

This special issue focuses on How Do HCPs Safely Reopen Their Practice After COVID-19 Quarantine? 

Recorded May 14, 2020

This is a part of the American Diabetes Associations ongoing project providing resources for practicing clinicians on the care of Diabetes during the Covid-19 pandemic.  Today’s discussion is an audio version of a webinar recorded on May 14, 2020.

Presented by:

Neil Skolnik, MD Thomas Jefferson University

John B. Lynch, MD, MPH University of Washington

This special issue focuses on Challenges and Opportunities to Help Vulnerable Populations during the COVID-19 Outbreak. 

Recorded April 23, 2020

This is a part of the American Diabetes Associations ongoing project providing resources for practicing clinicians on the care of Diabetes during the Covid-19 pandemic.  Today’s discussion is an audio version of a webinar recorded on April 23, 2020.

Presented by:

Enrique Caballero, MD Harvard Medical School

Ashby Walker, PhD University of Florida

Anne Harper, MS, RDN, CDE Alaska Native Tribal Health Consortium

Lisa Taylor, DNP, MSN, BSN Optum/United Health Group

Arshiya A. Baig, MD, MPH, FACP University of Chicago